Interferon-&bgr;_1a for the treatment of multiple sclerosis

By Clerico Marinella   Contessa Giulia   Durelli Luca  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 535-542

Informa Healthcare

Access to resources Recommend Favorite

Clinical effects and tolerability of high-dose, high-frequency recombinant interferon β-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence

By Boyko Alexey N  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients’ individual gene expression in peripheral blood

By Hecker Michael   Hartmann Christiane   Kandulski Ole   Paap Brigitte   Koczan Dirk   Thiesen Hans-Juergen   Zettl Uwe  

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 737-756

Humana Press, Inc

Access to resources Recommend Favorite

Natalizumab and the role of α₄-integrin antagonism in the treatment of multiple sclerosis

By O’Connor Paul  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells

By Li Yubin   Zhu Haiyan   Zeng Xian   Fan Jiajun   Qian Xiaolu   Wang Shaofei   Wang Ziyu   Sun Yun   Wang Xiaodan   Wang Weiwu   Ju Dianwen  

Molecular Neurobiology, Vol. 47, Iss. 3, 2013-06 ,pp. : 1000-1010

Humana Press, Inc

Access to resources Recommend Favorite